Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Collagen-based drug delivery and artificial tears.

Kaufman HE, Steinemann TL, Lehman E, Thompson HW, Varnell ED, Jacob-LaBarre JT, Gebhardt BM.

J Ocul Pharmacol. 1994 Spring;10(1):17-27.

PMID:
8207324
2.

[New approaches in topical drug administration and treatment of the dry eye].

Kaufman HE.

Klin Monbl Augenheilkd. 1993 Mar;202(3):195-8. Review. German.

PMID:
8510412
3.

Tear film, pharmacology of eye drops, and toxicity.

Palmer RM, Kaufman HE.

Curr Opin Ophthalmol. 1995 Aug;6(4):11-6. Review.

PMID:
10150876
4.

Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.

Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C.

Invest Ophthalmol Vis Sci. 2001 Jan;42(1):90-5.

PMID:
11133852
5.

Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.

Berdoulay A, English RV, Nadelstein B.

Vet Ophthalmol. 2005 Jul-Aug;8(4):225-32.

PMID:
16008701
6.

Ophthalmic drug delivery systems--recent advances.

Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R.

Prog Retin Eye Res. 1998 Jan;17(1):33-58. Review.

PMID:
9537794
7.

Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.

Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK.

Ophthalmology. 2006 Feb;113(2):198-205. Epub 2005 Dec 19.

PMID:
16360211
8.

Sucralfate and sodium sucrose sulphate in the treatment of superficial corneal disease in keratoconjunctivitis sicca.

van Bijsterveld OP, van Hemel OL.

Acta Ophthalmol (Copenh). 1992 Aug;70(4):518-21.

PMID:
1414298
9.

[Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].

Galatoire O, Baudouin C, Pisella PJ, Brignole F.

J Fr Ophtalmol. 2003 Apr;26(4):337-43. French.

10.

A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.

Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R.

Am J Ophthalmol. 2004 Sep;138(3):444-57.

PMID:
15364229
11.

The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome.

Nepp J, Schauersberger J, Schild G, Jandrasits K, Haslinger-Akramian J, Derbolav A, Wedrich A.

Biomaterials. 2001 Dec;22(24):3305-10.

PMID:
11700802
12.

Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.

Sand BB, Marner K, Norn MS.

Acta Ophthalmol (Copenh). 1989 Apr;67(2):181-3.

PMID:
2658462
13.

Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.

Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C.

Invest Ophthalmol Vis Sci. 2000 May;41(6):1356-63.

PMID:
10798650
14.
15.

Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.

Hariprasad SM, Shah GK, Chi J, Prince RA.

J Cataract Refract Surg. 2005 Nov;31(11):2142-6.

PMID:
16412929
16.

The collagen shield. A new vehicle for delivery of cyclosporin A to the eye.

Reidy JJ, Gebhardt BM, Kaufman HE.

Cornea. 1990 Jul;9(3):196-9.

PMID:
2373013
17.

Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond.

Wright P, Cooper M, Gilvarry AM.

Br J Ophthalmol. 1987 Feb;71(2):161-4.

18.

Low spatial-contrast sensitivity in dry eyes.

Rolando M, Iester M, Macrí A, Calabria G.

Cornea. 1998 Jul;17(4):376-9.

PMID:
9676908
19.

Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.

Liu Z, Pflugfelder SC.

Ophthalmology. 1999 May;106(5):939-43.

PMID:
10328393

Supplemental Content

Support Center